[Dementia in the Lewy Body Disease Spectrum].

Area of Science:

• Neurology
• Neuroscience
• Pathology

Background:

• Parkinson's disease (PD) frequently involves cognitive decline.
• Dementia onset timing and predictors in PD patients remain areas of active research.
• Understanding the neuropathological underpinnings is crucial for therapeutic development.

Purpose of the Study:

• To identify key predictors for early dementia onset in Parkinson's disease.
• To elucidate the neuropathological basis of dementia in PD.
• To evaluate the efficacy of cholinesterase inhibitors for managing dementia symptoms in PD.

Main Methods:

• Retrospective analysis of patient data.
• Clinical assessment of motor, sleep, and cognitive functions.
• Neuropathological examination of brain tissue.

Main Results:

• Significant variability in dementia onset timing was observed.
• Postural instability, gait disturbance, REM sleep behavior disorder, and visuo-spatial impairment predicted early dementia.
• Co-occurrence of alpha-synuclein and Alzheimer's disease co-pathology was identified as the main neuropathological basis.
• Cholinergic system degeneration correlated with symptom severity.

Conclusions:

• Early identification of dementia risk in PD is possible through specific clinical markers.
• Combined alpha-synuclein and Alzheimer's pathology characterize PD dementia.
• Targeting the cholinergic system with cholinesterase inhibitors can improve visual hallucinations and cognitive deficits in PD dementia.